Universe Pharmaceuticals INC Capital Expenditures Incurred but Not yet Paid
Universe Pharmaceuticals INC (UPC) reported Capital Expenditures Incurred but Not yet Paid of $282.20 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-01-29
| Period end | Capital Expenditures Incurred but Not yet Paid | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|
| 2025-09-30 | $282.20M 20-F · filed 2026-01-29 | |
| 2024-09-30 | $342.48M 20-F · filed 2026-01-29 | |
| 2024-03-31 | $3.40M 6-K · filed 2024-09-20 | |
| 2023-09-30 | $3.40M 20-F · filed 2024-01-30 |